Business & Finance

Bayer AG, the chemical/pharmaceutical giant, vaulted into the top three in the over-the-counter medications market by agreeing to buy Roche Consumer Health, the nonprescription drug subsidiary of Switzerland's Roche Holding. The sale price was reported to be $2.97 billion. The deal does not include Roche's over-the-counter business in Japan, Bloomberg.com reported. The over-the-counter industry leaders are Pfizer Inc. and Johnson & Johnson, both of the US.

In a deal valued at $1.05 billion, the No. 2 bank in Portugal said it will sell its insurance subsidiaries to larger rival Caixa Geral de Depositos SA and to Fortis, the Belgian financial-services giant. Banco Comercial Português SA had tried to unload the insurance units for two years to concentrate on retail banking, Bloomberg.com reported.

About these ads
Sponsored Content by LockerDome

We want to hear, did we miss an angle we should have covered? Should we come back to this topic? Or just give us a rating for this story. We want to hear from you.

Loading...

Loading...

Loading...

Save for later

Save
Cancel

Saved ( of items)

This item has been saved to read later from any device.
Access saved items through your user name at the top of the page.

View Saved Items

OK

Failed to save

You reached the limit of 20 saved items.
Please visit following link to manage you saved items.

View Saved Items

OK

Failed to save

You have already saved this item.

View Saved Items

OK